Zenith Capital Corp.

FRC's fair value estimate for Zenith Capital Corp., and the rating behind it. ZHCLF last traded at $0.10; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for Zenith Capital Corp.. Starting points for Zenith Capital Corp.: EPS -$0.05, beta -161.71 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for Zenith Capital Corp.. Zenith Capital Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for Zenith Capital Corp.. Trailing twelve-month EPS for Zenith Capital Corp. stands at -$0.05. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for Zenith Capital Corp.. Zenith Capital Corp. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Zenith Capital Corp. valued side by side against its closest peers. Zenith Capital Corp. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold Zenith Capital Corp., and how their positions are changing. At a $15.9M market value, institutional positions materially move Zenith Capital Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by Zenith Capital Corp. executives and directors. Shares of Zenith Capital Corp. have traded between $0.0001 and $0.14 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming Zenith Capital Corp.. Zenith Capital Corp. is a $15.9M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming Zenith Capital Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for Zenith Capital Corp.. Coverage tracks Zenith Capital Corp. within Biotechnology (Healthcare). Press releases and market coverage, newest first.